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Abstract 
Hepatoma is a tumoral disease that consists in an abnormal proliferation of the hepatic cells. 
According to the augmentation of the risks factors such as smoking, alcohol abuse, 
consuming no healthy food and different types of viral and bacterial infections. Nowadays, 
this disease is becoming more evident even in the young ages. Here, we present a 63 old 
female with this disease. 
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Introduction 
Hepatoma is malignant disease that is also known as hepatocarcinoma ( HCC ) and is one of 
the most expressed tumoral disease of liver. It is seen a strong correlation between 
hepatocarcinoma and other chronic liver disease such as Hepatitis B, C, diabetes mellitus type 
2, or chirrosis etc. 
Also is evidented that being exposed to harmful factors such as alcohol abuse or being 
malnutried and with hipercaloric diet mainly in cholesterol and triglicerides ( that cause the 
fat’s accumulation in liver ) can bring an augmentation of Hepato cellular carcinoma disease. 
However, this disease is very similar in appearance with the metastasis that origins from the 
other organs such as colon, stomach etc. 
Most cases are treated with surgical resection and chemotherapy, but the prognosis is not very 
hopeful. 
Case report 
Here, we present a 63 years old woman with a poor symptomatic clinic. She refered light pain 
located in the dexter hypochondriac region of abdomen for about 6 months. Also she refered 
for weight reduction during the last 2 months and reduction of orexia. The feeling of being 
tired was becoming more and more evident and present day after day. 
A physical examination performed on her, did not show to us anything special expect a little 
bit abdominal pain mainly in the dexter hypochondriac region during a deep breathing. The 
others regions of abdomen were quiet and without muscular defense. 
An abdominal echography and thoraco/abdominal CT scan showed us a big neoformation 
(Ø48-51 mm ), located in the VII segment of hepar and infiltration of V and VIII segments. 
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Fig.1. Liver Neoformation 
According to the examinations we decided for a surgical treatement and realized a rezection 
of right lobe of liver. 
 
Fig.2 Lobectomy dexter                                                   Fig.3. Liver Neoformation 
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Fig.4 Liver Neoformation                                                  Fig.5.Lobectomy dexter 
 
Discussion 
Surgery rests as therapy of choice in patients with a minor, restricted number of tumor 
nodules. Up to date, no preoperative treatment has been validated useful. Adjuvant treatments 
involving systemic chemotherapy, intra-arterial infusion, or chemoembolization failed to 
increase survival, while immune therapy, retinoids, radiolabeled isotopes, and antiangiogenic 
agents appear encouraging. Systemic therapy with cytotoxic agents remains disappointing as 
to recent data. 
 
Conclusion 
Hepatocarcinoma is very malignant disease that interests the liver and beyond, including 
physiological reactions processes and with a high spread metastasis to other organs as well. A 
surgical approach along with chemotherapy was the most suitable management approach in 
this case. That we do have today the patient alive with clinical health aspects improved. 
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